Selecting a CRO is one of the highest-stakes decisions a sponsor makes in early clinical development. The wrong choice shows up months later, in missed timelines, inconsistent site management, or a Trial Master File that will not survive inspection. The right choice is rarely the one with the glossiest proposal.
1. Who will actually run my study?
Ask for the names and CVs of the people who will be on your study day to day, not the sales team who pitched you. Therapeutic and operational experience at the individual level matters more than the CRO's overall size.
2. How do you handle site underperformance?
Every CRO will say they monitor performance. Ask for a concrete example of a site that fell behind, what triggered the escalation, and what changed as a result.
3. What does your TMF look like mid-study, not at close-out?
A clean TMF at database lock tells you little. Ask to see how documents are tracked and reconciled while the study is live.
4. How is risk actually managed, not just documented?
Risk-based monitoring plans are now standard paperwork. The real question is what happens when a risk indicator is triggered, and how quickly it reaches someone who can act on it.
5. What is your escalation path when something goes wrong?
Get this in writing. Vague answers here are one of the clearest early warning signs of a CRO relationship that will require heavy sponsor oversight later.
6. How do you handle vendor and lab data integration?
Ask specifically how they manage discrepancies between EDC, labs, and safety databases, and who owns resolution when data does not reconcile.
7. Can you show me a study that went off track, and how you recovered it?
A CRO with a mature quality culture will answer this directly. One that only wants to talk about successes is telling you something too.
Getting an independent view before you sign
Sponsors and biotechs often bring in senior, independent expertise at exactly this stage, to review CRO proposals, sit in on capability assessments, and ask the harder operational questions before a contract is signed rather than after a study has drifted off track.
Our clinical trial consulting services support exactly this kind of decision point, from CRO evaluation to full study rescue assessments for programmes already underway.